BoWangLab retweeted
Our cells carry the same DNA, but how this DNA is interpreted differs wildly from cell to cell. In a new preprint, Science Fellow @zhou_jingtian and team introduce Bolero, a model conditioned on cell state that predicts chromatin accessibility and expression from DNA alone.
BoWangLab retweeted
The strongest, cleverest, most efficient and most under rated DNA language model for variant prioritization is "officially" published. Superb innovative work. A rare gem in the sea of parameter slop in AI for Bio.
We are thrilled to share that our GPN-Star manuscript is now published and freely available:
doi.org/10.1038/s41586-026-1…
(1/n)
BoWangLab retweeted
The man who cracked the biology behind Ozempic still works as a hospital doctor and made almost nothing, while the drug built on his discovery became the best-selling medicine on Earth.
His name is John Eng.
He worked at a Veterans Affairs hospital in the Bronx, treating diabetes patients all day and running experiments on the side. No big lab. No famous university behind him. Just a hospital bench and a question that would not leave him alone.
The question was about a lizard.
The Gila monster is a fat, slow desert lizard from Arizona. It eats maybe three or four times a year. That is not a typo. It can go months without a single meal and its blood sugar stays perfectly stable the entire time. No spikes. No crashes. A human who ate like that would be dead or in a coma. The lizard is fine.
In the early 1980s, some government researchers noticed that the venom of this lizard did something strange to the pancreas, the organ that controls blood sugar. They filed it away as a curiosity and moved on. Nobody chased it.
Eng chased it.
He could not exactly go catch a venomous lizard in the Bronx. So he did the only thing he could afford. He ordered dried, preserved Gila monster venom out of a mail-order catalog from a reptile supplier in Utah. It showed up in the post. He started pulling it apart to see what was inside.
In 1992 he found it. A molecule nobody had ever documented, hiding in the venom. He named it exendin-4.
Here is why it mattered.
Your own body makes a hormone that tells your pancreas to release insulin after you eat. It is called GLP-1. It works beautifully. There is just one problem. It falls apart in about two minutes. Your body destroys it almost as fast as it makes it, which makes it useless as a medicine. Scientists knew about it and kept hitting the same wall.
The lizard molecule did the exact same job. It walked up to the same door in your cells and opened it the same way. But it did not fall apart in two minutes. It kept working for hours. The lizard had evolved a version of the human hormone that survived. Nature had already solved the problem medicine was stuck on.
Eng knew what he was holding.
His own employer did not care. The VA refused to patent it, because a lizard diabetes drug did not count as a "veteran-specific" problem. So Eng paid for the patent himself. Out of his own pocket. A hospital doctor spending his own money to protect a discovery his bosses had shrugged at.
Then he went looking for a drug company to build it.
For three years, every door shut. A diabetes drug made from lizard spit sounded like a joke. Serious pharmaceutical people did not want their name on it. One scientist who watched it happen said Eng was completely frustrated, that none of the important people would even look at him.
In 1996 he pinned a poster to a wall at a diabetes conference and stood next to it. Most people walked past. One researcher from a small California company called Amylin stopped and actually read it. One month later they licensed his patent.
That poster became a drug called Byetta. The FDA approved it in 2005, thirteen years after Eng first pulled the molecule out of that mail-order venom. It was the first drug of its kind ever sold. A twice-a-day shot for diabetes, grown from the spit of a lizard that eats twice a year.
Byetta was the proof. It showed the whole world that this pathway worked in real humans. And once everyone could see it worked, the giants moved in.
A Danish company took the same idea and built a better version. Instead of copying the lizard, they modified the human hormone directly so it would survive in the body the way the lizard's did. That drug is semaglutide. You know it by its other names. Ozempic. Wegovy.
So no, Ozempic is not literally lizard venom. It is built from the human hormone. But nobody would have built it if a lizard in the desert had not proven the whole idea could work first, and if one Bronx doctor had not refused to let that proof die on a shelf.
In 2025 alone, that single family of drugs did over 48 billion dollars in sales. It has become the best-selling prescription medicine on the planet. Celebrities take it. Your neighbors take it. It is on every feed you scroll. People treat it like it appeared out of nowhere two years ago.
It did not. The door it walks through was found in lizard venom by a hospital doctor who bought his samples by mail.
Here is the part that should sit with you.
John Eng got paid for Byetta, the drug built directly from his lizard molecule. But Ozempic and Wegovy, the ones worth tens of billions, were built from the human hormone instead of his exendin-4. So he does not collect a cent from the biggest drug story in the world. The man who proved the whole thing was possible watches the boom from the outside.
Every person injecting themselves this week is using a door that a lizard evolved and a forgotten doctor refused to stop knocking on.
The molecule was always there. The lizard had it the whole time.
It just took one man who wouldn't stop asking why a monster in the desert never goes hungry.
BoWangLab retweeted
📢Thrilled to announce that the 2nd piece of work from my postdoc at @Arlottalab is out in @Nature! This has been a huge co-lead effort with my friend @IreneFaravelli 👩🔬👩🔬🤝
Link: nature.com/articles/s41586-0…
👇🧵
BoWangLab retweeted
The issue features the discovery of a cytotoxic cell type in planarians called “ruptoblasts” cell.com/cell/fulltext/S0092…
BoWangLab retweeted
“Why haven’t scientists cured cancer yet” is the biggest complaint you hear about biomedical research. Even @stephenathome on The Late Show would ask, in his segments on wacky research, “that cancer cure, how’s that going?”
Today I’m excited to share our new study in Nature Biomedical Engineering @natBME , in which we used protein engineering to create a therapeutic able to completely eradicate metastatic ovarian cancer in mice. 🧵
BoWangLab retweeted
Stanford researchers have discovered a previously unknown immune cell in flatworms that helps coordinate responses to injury and infection. The finding offers new insight into the evolution of immune systems across species.
stanford.io/3SglrAF
BoWangLab retweeted
プラナリアにおいて、新規細胞傷害性腺細胞ruptoblastを同定し、activinによって誘導される爆発的細胞死ruptosisを介して細菌や哺乳類細胞を迅速に殺傷することで、ホルモンシグナルと自然免疫を結び付ける新たな防御機構を明らかにした論文がCell誌に発表されました。
cell.com/cell/abstract/S0092…
BoWangLab retweeted
1/8 Inside your body lies something ancient.
Our @PNASNews paper uncovers the deep unicellular prehistory of blood cell types. See paper and video.
@IBE_Barcelona @icreacommunity @PRBBIntervals @CSIC @CSICCat
pnas.org/doi/10.1073/pnas.25…
BoWangLab retweeted
The biggest bottleneck in building cell foundation models isn't the architecture. It's the data.
For scPRINT-2 we assembled what is, to our knowledge, the largest pre-training corpus for any cell foundation model. biorxiv.org/content/10.64898… 🧵
1/3
BoWangLab retweeted
We’re unwrapping a new method today @MSKCancerCenter!
Led by @SydneyBlattman, @NabihMaslah, @AustinAVarela, Ronan Chaligne and @dana_peer, plus colleagues at @10xGenomics, we’re delighted to share Genotyping In Fixed Transcriptomes (GIFT):
biorxiv.org/content/10.64898…
1/n
Nature research paper: An enteric neuron ionotropic receptor regulates salt stress resistance
go.nature.com/3Ogggz0
BoWangLab retweeted
Apparently it's AP-1 controls cellular memory week. Congrats @chris_cowley14 ! I guess I convinced you AP-1 is so interesting that you never need to work on anything else again...
science.org/doi/10.1126/scie…
BoWangLab retweeted
So excited to see this paper from @jess_ljx out in final form! One of the most beautiful papers from our lab: shows that a single cell can learn by forming memories to adapt to new challenges.
AP-1 mediates cellular adaptation and memory formation @NatureComms @PennMedicine
@arjunrajlab @PennGenetics
nature.com/articles/s41467-0…
BoWangLab retweeted
The first approved GLP1 (Byetta) came from a desert reptile, the Gila monster. Inspired by this, our work on Burmese pythons 🐍🐍 is now out @NatMetabolism. An “extreme”-ly fun collaboration with Leinwand and @DrYongXu1. Congratulations @Shuke_Xiao!
nature.com/articles/s42255-0…
BoWangLab retweeted
Ancient photoreceptor shapes behavioural responses
elifesciences.org/articles/1…
BoWangLab retweeted
Can we simulate realistic evolutionary trajectories and “replay the tape of life”? In this work, we propose a flexible, generalizable framework for modeling how the entire protein seq evolves over time while capturing complex interactions across sites. 1/n
doi.org/10.64898/2026.02.19.…
BoWangLab retweeted
Excited to share a recent publication from the lab. Daniel Benjamin & Jengmin Kang led the study of the allocation of resources to survival over reproduction in stem cells during aging. #EvolutionaryTradeOffs #SurvivorshipBias
science.org/doi/10.1126/scie…
BoWangLab retweeted
The new glutamate indicators were announced today in @naturemethods. nature.com/articles/s41592-0…




























